CAS RN: 3956-07-8
4-IODOBENZAMIDE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260403
1g / 5g / 25g / 100g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 3956-07-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
3956-07-8 / 4-iodobenzamide
Standard CAS: 3956-07-8
Multi CAS: Yes
Basic Information
copy
CAS
3956-07-8 copy
Multi CAS
Yes copy
Molecular Formula
C7H6InO copy
Molecular Weight
247.030000 copy
Exact Mass
246.949410 copy
InChI
InChI=1S/C7H6INO/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H2,9,10) copy
InChIKey
XRNBLQCAFWFFPM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
6 copy
Rotatable bonds
1 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
47.68 copy
TPSA
43.09 copy
LogP / Solubility
WLOGP
1.39 copy
MLOGP
1.23 copy
XLogP3
2 copy
Consensus LogP
1.54 copy
Log S (ESOL)
-2.63 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.59 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.54 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.24 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy